Table 2. Pattern of recurrence.
| |
|
|
|
P-values |
|||
|---|---|---|---|---|---|---|---|
| Total (N=72) | NMA (N=58) | AIM (N=4) | MAC (N=10) | AIM vs NMA | MAC vs NMA | AIM vs MAC | |
|
Pattern of recurrencea | |||||||
| Local recurrence | 10 (13.9%) | 8 (13.8%) | 1 (25.0%) | 1 (10.0%) | 0.48 | 1.00 | 0.505 |
| Distant metastasis |
62 (86.1%) |
50 (86.2%) |
3 (75.0%) |
9 (90.0%) |
|
|
|
|
Initial site involved in case of distant metastasisb | |||||||
| Lung | 25 (40.3%) | 22 (44.0%) | 1 (33.3%) | 2 (22.2%) | 1.00 | 0.29 | 1.00 |
| Liver | 19 (30.6%) | 17 (34.0%) | 0 (0%) | 2 (22.2%) | 0.54 | 0.70 | 1.00 |
| Lymph node | 19 (30.6%) | 17 (34.0%) | 2 (66.7%) | 0 (0%) | 0.29 | 0.048 | 0.045 |
| Peritoneum | 20 (32.3%) | 13 (26.0%) | 2 (66.7%) | 5 (55.6%) | 0.19 | 0.12 | 1.00 |
| Bone | 2 (3.2%) | 2 (4.0%) | 0 (0%) | 0 (0%) | 1.00 | 1.00 | — |
Abbreviations: AIM=adenocarcinoma with intermediate mucinous component; MAC=mucinous adenocarcinoma; NMA=non-mucinous adenocarcinoma.
a
Analysis among patients with recurrence.
b
Analysis among patients having distal metastasis.